Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




AI Model Identifies Signs of Disease Faster and More Accurately Than Humans

By LabMedica International staff writers
Posted on 25 Nov 2024

Traditionally, researchers and medical professionals identify pathology, or signs of disease, by meticulously examining and annotating tissue samples under a microscope, a process that can take hours for each slide or image. More...

Now, a "deep learning" artificial intelligence (AI) model can identify pathology in animal and human tissue images much more rapidly, and in many cases, with greater accuracy than humans. This development, outlined in Scientific Reports, could significantly accelerate disease-related research and holds promise for enhancing medical diagnoses, such as identifying cancer from biopsy images in just minutes.

To create the AI model, computer scientists at Washington State University (Pullman, WA, USA) trained it using images from prior epigenetic studies conducted by their team. These studies focused on molecular-level disease markers in tissues from rats and mice, including kidney, testes, ovarian, and prostate tissues. The researchers then tested the AI on images from additional studies, including those identifying breast cancer and lymph node metastasis. They discovered that the new AI model not only identified pathologies quickly but also did so faster than previous models, and in some cases, it detected instances that a trained human team had missed.

In epigenetic research, which examines changes to molecular processes influencing gene activity without altering the DNA itself, analysis can take years for large-scale studies. However, with the new AI model, the same data can be processed in just a few weeks. Deep learning is an advanced AI approach designed to replicate the human brain, surpassing traditional machine learning methods. This model is structured with a network of neurons and synapses. When the model makes an error, it "learns" from it using backpropagation, a technique that adjusts the network to correct the mistake, preventing it from happening again.

The research team developed the WSU deep learning model to process high-resolution, gigapixel images containing billions of pixels. To handle the large file sizes, which can slow down even powerful computers, the model analyzes smaller tiles of the image while maintaining their context within larger sections at lower resolution, similar to zooming in and out with a microscope. This model has already caught the attention of other researchers, with its potential to advance both research and diagnosis, especially in areas such as cancer and gene-related diseases. By using annotated images, such as those identifying cancer in tissue samples, researchers could train the AI model to perform similar tasks in medical settings.

“This AI-based deep learning program was very, very accurate at looking at these tissues,” said Michael Skinner, a WSU biologist and co-corresponding author on the paper. “It could revolutionize this type of medicine for both animals and humans, essentially better facilitating these kinds of analysis.”


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.